Mann, Amandeep
Chan, Ava
Rohatgi, Atharva
Caesar, Michelle Ann
Obedin-Maliver, Juno
Kapp, Daniel S.
Article History
Received: 16 July 2021
Accepted: 22 February 2022
First Online: 8 March 2022
Competing interests
: Dr. Juno Obedin-Maliver has consulted for Sage Therapeutics (5/2017) in a one-day advisory board, Ibis Reproductive Health (a non-for-profit research group 3/2017–5/2018), and Hims Inc. (2019—present). Amandeep Mann, Ava Chan, Atharva Rohatgi, Michelle Ann Caesar, and Dr. Daniel S Kapp do not have any competing interests.